BRIEF

on Zomedica Corp. (NASDAQ:ZOM)

Zomedica Expands UK Presence with Strategic Distribution Agreement

Zomedica Corp., a veterinary health company, has announced a strategic distribution partnership with Pioneer Veterinary Products Limited to strengthen its market position in the UK. This agreement aims to increase the availability of Zomedica's advanced diagnostic and therapeutic products for animals. Pioneer will distribute the TRUFORMA® diagnostic platform, with VETGuardian® remote monitoring technology expected to follow. This partnership offers exclusive sales support for small animal markets and non-exclusive distribution for equine products across the UK.

The TRUFORMA platform provides lab-quality results at point-of-care, enhancing the diagnosis of endocrine and thyroid conditions in pets. Pioneer anticipates integrating VETGuardian®, which offers wireless, real-time monitoring for animals, improving surgical and post-operative care. Zomedica's CEO, Larry Heaton, views this agreement as a crucial step in expanding their UK footprint and aligning with global market leadership ambitions.

Pioneer's Managing Director, Clive Groombridge, expresses enthusiasm for the collaboration, noting the alignment with their mission to support veterinary professionals. The partnership is set to improve access to advanced veterinary tools, thereby enhancing patient outcomes and practice efficiency in the UK.

R. H.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Zomedica Corp. news